CSF BIOMARKERS FOR AD: STATE OF THE ART AND NEW DEVELOPMENTS

被引：1
作者：
Blennow, Kaj [1 ]
机构：
[1] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
来源：
NEUROBIOLOGY OF AGING | 2014年 / 35卷
关键词：
Alzheimer's disease; biomarker; cerebrospinal fluid;
D O I：
10.1016/j.neurobiolaging.2014.01.037
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [41] Inflammatory Biomarkers in AD: Implications for Diagnosis
    Kim, Junhyung
    Kim, Yong-Ku
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (11) : 962 - 971
  • [42] Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease
    Hu, Yan
    Kauwe, John S. K.
    Gross, Julia
    Cairns, Nigel J.
    Goate, Alison M.
    Fagan, Anne M.
    Townsend, R. Reid
    Holtzman, David M.
    PROTEOMICS CLINICAL APPLICATIONS, 2007, 1 (11) : 1373 - 1384
  • [43] Novel CSF biomarkers for frontotemporal lobar degenerations
    Hu, W. T.
    Chen-Plotkin, A.
    Grossman, M.
    Arnold, S. E.
    Clark, C. M.
    Shaw, L. M.
    McCluskey, L.
    Elman, L.
    Hurtig, H. I.
    Siderowf, A.
    Lee, V. M. -Y.
    Soares, H.
    Trojanowski, J. Q.
    NEUROLOGY, 2010, 75 (23) : 2079 - 2086
  • [44] Biomarkers in amyotrophic lateral sclerosis: a review of new developments
    Verber, Nick
    Shaw, Pamela J.
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (05) : 662 - 668
  • [45] CSF biomarkers and clinical progression of Parkinson disease
    Hall, Sara
    Surova, Yulia
    Ohrfelt, Annika
    Zetterberg, Henrik
    Lindqvist, Daniel
    Hansson, Oskar
    NEUROLOGY, 2015, 84 (01) : 57 - 63
  • [46] CSF biomarkers in different phenotypes of Parkinson disease
    Jellinger, Kurt A.
    JOURNAL OF NEURAL TRANSMISSION, 2012, 119 (04) : 455 - 456
  • [47] Biomarkers in Motor Neuron Disease: A State of the Art Review
    Verber, Nick S.
    Shepheard, Stephanie P.
    Sassani, Matilde
    McDonough, Harry E.
    Moore, Sophie A.
    Alix, James J. P.
    Wilkinson, Iain D.
    Jenkins, Tom M.
    Shaw, Pamela J.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [48] Genetic Discoveries in AD Using CSF Amyloid and Tau
    Carlos Cruchaga
    Mark T. W. Ebbert
    John S. K. Kauwe
    Current Genetic Medicine Reports, 2014, 2 (1) : 23 - 29
  • [49] Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
    Salvado, Gemma
    Luis Molinuevo, Jose
    Brugulat-Serrat, Anna
    Falcon, Carles
    Grau-Rivera, Oriol
    Suarez-Calvet, Marc
    Pavia, Javier
    Ninerola-Baizan, Aida
    Perissinotti, Andres
    Lomena, Francisco
    Minguillon, Carolina
    Fauria, Karine
    Zetterberg, Henrik
    Blennow, Kaj
    Domingo Gispert, Juan
    Cami, Jordi
    Cacciaglia, Raffaele
    Crous-Bou, Marta
    Deulofeu, Carme
    Dominguez, Ruth
    Gotsens, Xavi
    Gramunt, Nina
    Hernandez, Laura
    Huesa, Gema
    Huguet, Jordi
    Leon, Maria
    Marne, Paula
    Menchon, Tania
    Mila, Marta
    Operto, Gregory
    Pascual, Maria
    Polo, Albina
    Pradas, Sandra
    Sala-Vila, Aleix
    Sanchez-Benavides, Gonzalo
    Segundo, Sabrina
    Soteras, Anna
    Tenas, Laia
    Vilanova, Marc
    Vilor-Tejedor, Natalia
    ALZHEIMERS RESEARCH & THERAPY, 2019, 11 (1)
  • [50] Influence of APOE ε4 on performance of CSF biomarkers in differentiating clinical Alzheimer's disease
    Wang, Yan
    Li, Fangyu
    Qin, Qi
    Li, Tingting
    Wang, Qi
    Li, Yan
    Li, Ying
    Jia, Jianping
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2025, 12 (04): : 100065
12345